Table 3 CDH1 three-marker haplotype analysis in diffuse gastric cancer cases

−160C → A

CTT

24.70

25

1.132

0.860

1.489

0.011

48 + 6 T → C

ATT

5.93

4.48

1.511

0.926

2.466

2076C → T

CCC

12.07

13.27

1.030

0.731

1.452

CTC

31.78

36.38

1

CCT

3.80

4.48

0.954

0.552

1.648

ATC

18.81

15.11

1.431

1.051

1.949

ACC

2.52

0.93

3.272

1.322

8.096

ACT

0.38

0.37

0.954

0.158

5.761

−160C → A

CTT

7.72

8.02

1.079

0.729

1.597

0.042

1937-13 T → C

ATT

1.41

0.75

2.073

0.732

5.872

2253C → T

CCC

3.20

3.36

1.075

0.599

1.929

CTC

61.22

67.53

1

CCT

0.21

0.19

0.691

0.062

7.648

ATC

23.34

18.47

1.4

1.078

1.819

ACC

2.86

16.79

0.184

0.111

0.306

ACT

0.04

0

–

–

–

−160C → A

CCT

1.62

14.93

0.108

0.055

0.212

0.096

2076C → T

ACT

0.09

0.19

0.691

0.058

7.227

2253C → T

CTC

37.54

42.91

0.909

0.703

1.176

CCC

26.88

27.99

1

CTT

6.31

6.72

0.987

0.628

1.551

ACC

6.23

4.66

1.406

0.862

2.293

ATC

19.97

15.49

1.332

0.971

1.827

ATT

1.37

0.56

2.341

0.771

7.111

−160C → A

CTC

53.84

58.79

0.904

0.470

1.739

0.103

48 + 6 T → C

ATC

22.01

17.91

1.21

0.613

2.389

1937-13 T → C

CCT

0.77

0.93

0.882

0.237

3.281

CTT

2.65

2.61

1

CCC

15.10

16.79

0.888

0.445

1.772

ATT

2.73

1.68

1.588

0.616

4.094

ACT

0.17

0

–

–

–

ACC

2.73

1.31

2.021

0.754

5.416